Close

Tag: Doses

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new patent from the United States patent office covering proprietary manufacturing technology for its revolutionary immunisation...

In Developing Nations, mRNA Boosters Can Be Great Investment

Because of their inexpensive cost, vaccinations made with inactivated SARS-CoV-2 viruses are widely used in underdeveloped countries. As per new research from Sweden's Karolinska...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read